Literature DB >> 16287587

Early undifferentiated arthritis.

Carol A Hitchon1, Christine A Peschken, Saeed Shaikh, Hani S El-Gabalawy.   

Abstract

Patients who cannot be classified as having a well-defined arthropathy typically are labeled as having undifferentiated arthritis. Some patients develop sufficient features to permit classification, whereas others remain undifferentiated, but with persistent joint inflammation, functional disability, and development of radiographic damage. Identifying the subset of patients destined to develop rheumatoid arthritis, spondyloarthropathy, or a more severe and persistent form of undifferentiated arthritis and choosing appropriate treatment strategies remain challenges for clinicians. Numerous investigative strategies are available with which to characterize undifferentiated arthritis and assess prognosis. This article discusses the characteristics of undifferentiated arthritis at presentation and the investigative strategies that can be used to predict prognosis and outcome early in the disease course. Therapeutic strategies also are explored.

Entities:  

Mesh:

Year:  2005        PMID: 16287587     DOI: 10.1016/j.rdc.2005.07.006

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  7 in total

1.  Detection of Shigella spp. nucleic acids in the synovial tissue of Tunisian rheumatoid arthritis patients and other forms of arthritis by quantitative real-time polymerase chain reaction.

Authors:  Mariam Siala; Markus Rihl; Hanen Sellami; Abir Znazen; Nadia Sassi; Lilia Laadhar; Radhouane Gdoura; Imen Belghuith; Dalila Mrabet; Sofien Baklouti; Slaheddine Sellami; Jean Sibilia; Hela Fourati; Adnene Hammami; Ilhem Cheour
Journal:  Rheumatol Int       Date:  2018-02-05       Impact factor: 2.631

2.  The role of human xanthine oxidoreductase (HXOR), anti-HXOR antibodies, and microorganisms in synovial fluid of patients with joint inflammation.

Authors:  Najah Al-Muhtaseb; Elham Al-Kaissi; Abdul Jalil Thawaini; Zuhair Muhi Eldeen; Sabah Al-Muhtaseb; Badiee Al-Saleh
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

3.  Early rheumatoid arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-Le Signe).

Authors:  Maurizio Benucci; Emanuela Cammelli; Mariangela Manfredi; Gianantonio Saviola; Paola Baiardi; Alessandro Mannoni
Journal:  Rheumatol Int       Date:  2008-01-30       Impact factor: 2.631

4.  The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis.

Authors:  Yi Chen; Lang Chen; Changsheng Xing; Guangtong Deng; Furong Zeng; Tingting Xie; Lei Gu; Huixiang Yang
Journal:  BMC Gastroenterol       Date:  2020-06-17       Impact factor: 3.067

5.  Broad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis.

Authors:  Mariam Siala; Radhouane Gdoura; Hela Fourati; Markus Rihl; Benoit Jaulhac; Mohamed Younes; Jean Sibilia; Sofien Baklouti; Naceur Bargaoui; Slaheddine Sellami; Abdelghani Sghir; Adnane Hammami
Journal:  Arthritis Res Ther       Date:  2009-07-01       Impact factor: 5.156

6.  Analysis of bacterial DNA in synovial tissue of Tunisian patients with reactive and undifferentiated arthritis by broad-range PCR, cloning and sequencing.

Authors:  Mariam Siala; Benoit Jaulhac; Radhouane Gdoura; Jean Sibilia; Hela Fourati; Mohamed Younes; Sofien Baklouti; Naceur Bargaoui; Slaheddine Sellami; Abir Znazen; Cathy Barthel; Elody Collin; Adnane Hammami; Abdelghani Sghir
Journal:  Arthritis Res Ther       Date:  2008-04-14       Impact factor: 5.156

7.  Predicting persistent inflammatory arthritis amongst early arthritis clinic patients in the UK: is musculoskeletal ultrasound required?

Authors:  Arthur G Pratt; Alice R Lorenzi; Gill Wilson; Philip N Platt; John D Isaacs
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.